Harbor Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-2,405
Closed -$204K 165
2018
Q4
$204K Hold
2,405
0.08% 152
2018
Q3
$412K Hold
2,405
0.13% 107
2018
Q2
$311K Sell
2,405
-2,244
-48% -$290K 0.1% 134
2018
Q1
$479K Hold
4,649
0.16% 92
2017
Q4
$397K Buy
4,649
+2,244
+93% +$192K 0.13% 103
2017
Q3
$204K Buy
+2,405
New +$204K 0.07% 148